Research Article
Role of miRNA-495 and NRXN-1 and CNTN-1 mRNA Expression and Its Prognostic Importance in Breast Cancer Patients
Table 4
Association of CNTN-1 mRNA expression in breast cancer cases with different clinicopathological features.
| Variables | CNTN-1 mRNA expression | value | Mean | SD |
| Relative expression | 4.92 | 3.02 | — |
| Age | ≤50 years | 4.35 | 3.88 | 0.03 | >50 years | 5.60 | 3.55 |
| Menopause | Yes | 4.98 | 3.68 | 0.72 | No | 4.81 | 3.99 |
| Lymph nodes | Yes | 5.97 | 3.99 | 0.01 | No | 4.10 | 3.39 |
| ER status | Yes | 5.97 | 4.0 | 0.06 | No | 4.45 | 4.59 |
| PR status | Yes | 6.19 | 3.90 | 0.03 | No | 4.44 | 3.62 |
| HER2 status | Yes | 5.92 | 4.21 | 0.04 | No | 4.26 | 3.30 |
| TNM stages | Early stage (I & II) | 1.72 | 1.24 | <0.0001 | Advanced stage (III & IV) | 6.89 | 3.43 |
| Distant metastases | Yes | 8.85 | 3.92 | <0.0001 | No | 3.68 | 2.74 |
|
|